BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Recruitment milestone reached in Diamyd® Phase 3 trial

  Diamyd Medical’s precision medicine Phase 3 trial for Type 1 Diabetes, DIAGNODE-3, has enrolled 100 patients.

  April 12, 2024

   · 

  4 min read
• Drug Development

  T-cell therapy developer, Cbio A/S Unveils 2023 Annual Report Amid Clinical Trial Preparations, Signaling Major Shift to Clinical Stage with DKK40M Financing Secured

  Cbio A/S – Pioneering Next-Gen T-Cell Therapies for Solid Tumors, Unveils 2023 Financial Results and Company Updates.

  April 12, 2024

   · 

  2 min read
• Business

  NHI Announces First Quarter 2024 Earnings Release and Conference Call Date

  National Health Investors, Inc. (NYSE:NHI) announced details for the release of its results for the first quarter ended March 31, 2024.

  April 12, 2024

   · 

  1 min read
• Pharm Country

  Ocugen to Participate in Fireside Chat at the Emerging Growth Virtual Healthcare Equity Conference, Presented by Noble Capital Markets

  Ocugen, Inc today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder will participate in a fireside chat during the Emerging Growth Virtual Healthcare Equity Conference, presented by Noble Capital Markets, taking place from April 17 – 18, 2024.

  April 12, 2024

   · 

  3 min read
• Genetown

  Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference

  Compass Therapeutics, Inc. today announced poster presentations on CTX-009, the Company’s bispecific DLL4/VEGF-A antibody, at the Cholangiocarcinoma Foundation (CCF) 2024 Annual Conference to be held at the Salt Palace Convention Center in Salt Lake City, Utah from April 17–19, 2024.

  April 12, 2024

   · 

  3 min read
• Business

  Notable Labs Reports 2023 Financial Results and Provides a Business Update

  Notable Labs, Ltd. reported financial results for the year ended December 31, 2023 and provided a business update.

  April 12, 2024

   · 

  9 min read
• Pharm Country

  Syntec Optics (Nasdaq: OPTX) Secures Order to Develop New Disposable Optics for Digital Health Treatment

  Syntec Optics announced today the launch of process development for a high-volume production line to make disposable medical optics.

  April 12, 2024

   · 

  5 min read
• Genetown

  Seismic Therapeutic Presents Preclinical Data on S-1117, its Novel Pan-IgG Protease Addressing Multiple Pathogenic Mechanisms in Autoimmune Disease, at American Academy of Neurology (AAN) 2024

  Seismic Therapeutic, Inc today announced the presentation of preclinical data for its pan‑immunoglobulin G (IgG) sculpting enzyme candidate, S-1117, at the American Academy of Neurology (AAN) 2024 annual meeting in Denver.

  April 12, 2024

   · 

  3 min read
• Genetown

  Prilenia to Present Latest Research from its Pridopidine Programs for Huntington Disease and ALS at AAN 2024

  Prilenia Therapeutics B.V. today announced the presentation of the latest research from the pridopidine Huntington disease (HD) and amyotrophic lateral sclerosis (ALS) programs at the American Academy of Neurology (AAN) Annual Congress, in Denver, Colorado, April 13-18.

  April 12, 2024

   · 

  4 min read
• American Aires Announces Record Q4 and Annual 2023 Order Volume and Significant Q4 EBITDA Profitability

  American Aires Inc. (CSE: WIFI) (OTC Pink: AAIRF) (“Aires” or the “Company”), a pioneer in cutting-edge technology designed to protect against electromagnetic

  April 12, 2024

   · 

  14 min read